Evolution of CPMAS Under Fast Magic-angle-spinning at 100 KHz and Beyond
Overview
Authors
Affiliations
This article describes recent trends of high-field solid-state NMR (SSNMR) experiments for small organic molecules and biomolecules using (13)C and (15)N CPMAS under ultra-fast MAS at a spinning speed (νR) of 80-100kHz. First, we illustrate major differences between a modern low-power RF scheme using UFMAS in an ultra-high field and a traditional CPMAS scheme using a moderate sample spinning in a lower field. Features and sensitivity advantage of a low-power RF scheme using UFMAS and a small sample coil are summarized for CPMAS-based experiments. Our 1D (13)C CPMAS experiments for uniformly (13)C- and (15)N-labeled alanine demonstrated that the sensitivity per given sample amount obtained at νR of 100kHz and a (1)H NMR frequency (νH) of 750.1MHz is ~10 fold higher than that of a traditional CPMAS experiment obtained at νR of 20kHz and νH of 400.2MHz. A comparison of different (1)H-decoupling schemes in CPMAS at νR of 100kHz for the same sample demonstrated that low-power WALTZ-16 decoupling unexpectedly displayed superior performance over traditional low-power schemes designed for SSNMR such as TPPM and XiX in a range of decoupling field strengths of 5-20kHz. Excellent (1)H decoupling performance of WALTZ-16 was confirmed on a protein microcrystal sample of GB1 at νR of 80kHz. We also discuss the feasibility of a SSNMR microanalysis of a GB1 protein sample in a scale of 1nmol to 80nmol by (1)H-detected 2D (15)N/(1)H SSNMR by a synergetic use of a high field, a low-power RF scheme, a paramagnetic-assisted condensed data collection (PACC), and UFMAS.
Nishiyama Y, Hou G, Agarwal V, Su Y, Ramamoorthy A Chem Rev. 2022; 123(3):918-988.
PMID: 36542732 PMC: 10319395. DOI: 10.1021/acs.chemrev.2c00197.
Wickramasinghe A, Xiao Y, Kobayashi N, Wang S, Scherpelz K, Yamazaki T J Am Chem Soc. 2021; 143(30):11462-11472.
PMID: 34308630 PMC: 10279877. DOI: 10.1021/jacs.1c03346.
Ultrafast H MAS NMR Crystallography for Natural Abundance Pharmaceutical Compounds.
Struppe J, Quinn C, Sarkar S, Gronenborn A, Polenova T Mol Pharm. 2020; 17(2):674-682.
PMID: 31891271 PMC: 7307729. DOI: 10.1021/acs.molpharmaceut.9b01157.
Wang S, Gopinath T, Veglia G J Biomol NMR. 2019; 73(10-11):617-624.
PMID: 31463642 PMC: 6861693. DOI: 10.1007/s10858-019-00273-1.
Ishii Y, Wickramasinghe A, Matsuda I, Endo Y, Ishii Y, Nishiyama Y J Magn Reson. 2017; 286:99-109.
PMID: 29223566 PMC: 6387629. DOI: 10.1016/j.jmr.2017.11.011.